How Much Did GC Therapeutics Raise? Funding & Key Investors

Date
May 16, 2025
GC Therapeutics

Total amount raised

$65.3 Million

Latest funding date

2024-09-19

GC Therapeutics

Location

Title

LINKEDIN

GC Therapeutics has developed a "plug-and-play" induced pluripotent stem cell (iPSC) cellular programming platform called TFome™, designed to overcome the complexities of cell therapy development and scaling. The platform leverages synthetic biology, gene editing, cell engineering, and machine learning to deliver iPSC-based medicines more rapidly and efficiently.

Research any company or contact with Clay
Get verified emails, company info, funding data and more with Clay
Try Clay for Free ->
https://www.gc-tx.com
Use Clay to find other emails
Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

What Is GC Therapeutics?

GC Therapeutics is a biotechnology company specializing in cell therapy and regenerative medicine. The company leverages its TFome™ platform to revolutionize cell therapy by using advancements in synthetic biology, gene editing, cell engineering, and machine learning.

Founded by George Church, Ph.D., and Parastoo Khoshakhlagh, Ph.D., GC Therapeutics focuses on developing therapies for gastrointestinal, neurological, and immunological diseases. The team is composed of visionary scientists and operators dedicated to pushing the boundaries of cell therapy.

How Much Funding Has GC Therapeutics Raised?

  1. Seed Round
    • Amount Raised: USD 339,893
    • Date: October 2023
  2. Series A Round
    • Amount Raised: USD 65,000,000
    • Date: September 2024
    • Lead Investors: Alumni Ventures, Cormorant Asset Management

GC Therapeutics has raised a total of USD 65,339,893 in funding.

Key Investors

  • Alumni Ventures
    • Details: Alumni Ventures is a venture capital firm that invests in high-growth startups. They leverage a network of alumni from top universities to identify and support promising companies.
    • Investment Focus Areas: Technology, healthcare, consumer products
    • Notable Investments: SpaceX, Robinhood, DraftKings
  • Cormorant Asset Management
    • Details: Cormorant Asset Management is a healthcare-focused investment firm. They specialize in investing in innovative biotechnology and life sciences companies.
    • Investment Focus Areas: Biotechnology, pharmaceuticals, medical devices
    • Notable Investments: Moderna, CRISPR Therapeutics, Intellia Therapeutics

Use Clay to Get Funding Data

Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like GC Therapeutics and gather other critical business insights. Sign up for free to start transforming your sales strategy today.

Find contacts at GC Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

Company Overview

Industry
Founded
Headquarters
Revenue
FUNDING Stage
Key Executives

Tech Stack

Key Executives

Group Chairman

Find the current person →

Group Chief Risk Officer

Find the current person →

Group Chairman

Find the current person →

Group Chief Executive Officer

Find the current person →

Chief Compliance Officer

Find the current person →

Group Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

FAQ

Group Chairman

Find the current person →

Group Chief Risk Officer

Find the current person →

Group Chairman

Find the current person →

Group Chief Executive Officer

Find the current person →

Chief Compliance Officer

Find the current person →

Group Chairman

Find the current person →

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles